Gerresheimer has officially started operations at its new pharmaceutical glass packaging facility in Zhenjiang Dagang, Jiangsu Province, China, strengthening its production capacity for the country’s growing pharmaceutical and biotechnology markets.

Built over approximately four years, the new 40,000 m² facility is located in the Zhenjiang Economic Development Zone and has been designed to meet the strict regulatory requirements of the pharmaceutical industry. The site also includes an additional 33,000 m² of land reserved for future expansion.

The plant manufactures borosilicate glass vials and ampoules for injectable medicines, primarily serving the Chinese market. Production is supported by more than 2,700 m² of ISO Class 8 cleanroom space, an ISO Class 7 microbiological laboratory, and over 700 m² of ISO Class 8 cleanroom area dedicated to silicone coating. The facility also operates under certified quality and environmental management systems.

Around 250 employees currently work at the site, with plans to create approximately 50 additional jobs in the coming years.

The new facility is Gerresheimer’s fourth Tubular Glass plant in China, expanding its long-standing joint venture with Shuangfeng Glass, which has now operated for more than 20 years.

Designed with sustainability in mind, the plant follows China’s “Green Factory” guidelines and LEED Gold certification requirements. A 2 MWp rooftop photovoltaic system generates renewable electricity for on-site use, while rainwater, condensate and production waste heat are recovered and reused, improving resource efficiency and supporting Gerresheimer’s long-term sustainability goals.